OUTSOURCED DRUG DISCOVERY MARKET ANALYSIS - (2019-2026)
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development.
Market Dynamics
New strategies adopted by key players related to outsourcing drug discovery is expected to drive growth of global outsourced drug discovery market. For instance, in June 2019, GlaxoSmithKline (GSK), a British drug manufacturing company collaborated with the University of California to establish a state-of-the-art laboratory for CRISPR technologies, the Laboratory for Genomics Research (LGR), in San Francisco. The new laboratory will investigate how gene mutations cause diseases, and also develop new technologies using CRISPR to rapidly accelerate the discovery of new medicines.
Furthermore, extension of partnership activities is expected to propel global outsourced drug discovery market growth. For instance, in March 2017, Charles River Laboratories (CRL) extended its partnership with Chiesi Farmaceutici. Under this partnership, Charles River Laboratories (CRL) extended its longstanding, strategic, integrated drug discovery program (Respiratory Program). The respiratory program is related to the preclinical drug development for treatment of respiratory diseases and rare diseases.
Request Sample Free Copy of Report here: https://www.coherentmarketinsights.com/insight/request-sample/2847
Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2847
Key features of the study:
- This report provides in-depth analysis of the outsourced drug discovery market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2019–2026), considering 2017, as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global outsourced drug discovery market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include, Aurigene Accelerating Discovery, Bioduro LLC, Charles River Laboratories (CRL), Chempartner, TCG Lifesciences, Evotec AG, Syngene International Ltd. Jubilant Biosys Ltd, Pharmaron Inc., Shanghai Medicilon, and Sundia Meditech Co. Ltd.
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global outsourced drug discovery market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for anesthesia device market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Global Outsourced Drug Discovery Market, By Drug Type:
- Small Molecule Drugs
- Large Molecule Drugs
Global Outsourced Drug Discovery market, By Services:
- Preclinical Development
- Target Validation and Functional Informatics
- Target Identification and Screening
- Lead Identification and Candidate Optimization
- Others
Global Outsourced Drug Discovery Market, By Application
- Oncology
- Ophthalmology
- Hematology
- Immunomodulation
- Anti-Infective Drugs
- Dermatology
- Pulmonology
- Cardiology
- Others
Global Outsourced Drug Discovery market, By End User
- Pharmaceutical and Biotechnological Companies
- Contract Research Organization
- Contract Manufacturing Organization
Global Outsourced Drug Discovery market, By Region:
- North America
- By Country:
- U.S.
- Canada
- By Drug Type:
- Small Molecule Drugs
- Large Molecule Drugs
- By Services:
- Preclinical Development
- Target Validation and Functional Informatics
- Target Identification and Screening
- Lead Identification and Candidate Optimization
- Others
- By Application
- Oncology
- Ophthalmology
- Hematology
- Immunomodulation
- Anti-Infective Drugs
- Dermatology
- Pulmonology
- Cardiology
- Others
- By End User
- Pharmaceutical and Biotechnological Companies
- Contract Research Organization
- Contract Manufacturing Organization
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Drug Type:
- Small Molecule Drugs
- Large Molecule Drugs
- By Services:
- Preclinical Development
- Target Validation and Functional Informatics
- Target Identification and Screening
- Lead Identification and Candidate Optimization
- Others
- By Application
- Oncology
- Ophthalmology
- Hematology
- Immunomodulation
- Anti-Infective Drugs
- Dermatology
- Pulmonology
- Cardiology
- Others
- By End User
- Pharmaceutical and Biotechnological Companies
- Contract Research Organization
- Contract Manufacturing Organization
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- By Drug Type:
- Small Molecule Drugs
- Large Molecule Drugs
- By Services:
- Preclinical Development
- Target Validation and Functional Informatics
- Target Identification and Screening
- Lead Identification and Candidate Optimization
- Others
- By Application
- Oncology
- Ophthalmology
- Hematology
- Immunomodulation
- Anti-Infective Drugs
- Dermatology
- Pulmonology
- Cardiology
- Others
- By End User
- Pharmaceutical and Biotechnological Companies
- Contract Research Organization
- Contract Manufacturing Organization
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Drug Type:
- Small Molecule Drugs
- Large Molecule Drugs
- By Services:
- Preclinical Development
- Target Validation and Functional Informatics
- Target Identification and Screening
- Lead Identification and Candidate Optimization
- Others
- By Application
- Oncology
- Ophthalmology
- Hematology
- Immunomodulation
- Anti-Infective Drugs
- Dermatology
- Pulmonology
- Cardiology
- Others
- By End User
- Pharmaceutical and Biotechnological Companies
- Contract Research Organization
- Contract Manufacturing Organization
- Middle East
- By Country/Region:
- GCC
- Israel
- Rest of Middle East
- By Drug Type:
- Small Molecule Drugs
- Large Molecule Drugs
- By Services:
- Preclinical Development
- Target Validation and Functional Informatics
- Target Identification and Screening
- Lead Identification and Candidate Optimization
- Others
- By Application
- Oncology
- Ophthalmology
- Hematology
- Immunomodulation
- Anti-Infective Drugs
- Dermatology
- Pulmonology
- Cardiology
- Others
- By End User
- Pharmaceutical and Biotechnological Companies
- Contract Research Organization
- Contract Manufacturing Organization
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Drug Type:
- Small Molecule Drugs
- Large Molecule Drugs
- By Services:
- Preclinical Development
- Target Validation and Functional Informatics
- Target Identification and Screening
- Lead Identification and Candidate Optimization
- Others
- By Application
- Oncology
- Ophthalmology
- Hematology
- Immunomodulation
- Anti-Infective Drugs
- Dermatology
- Pulmonology
- Cardiology
- Others
- By End User
- Pharmaceutical and Biotechnological Companies
- Contract Research Organization
- Contract Manufacturing Organization
- Company Profiles
- Aurigene Accelerating Discovery,*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Bioduro LLC.
- Charles River Laboratories (CRL)
- TCG Lifesciences
- Evotec AG
- Syngene International Ltd.
- Jubilant Biosys Ltd.
- Pharmaron Inc.
- Shanghai Medicilon Inc.
- Sundia Meditech Co. Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.
What we provide:
- Customized Market Research Services
- Industry Analysis Services
- Business Consulting Services
- Market Intelligence Services
- Long term Engagement Model
- Country Specific Analysis
Mr. Shah
Coherent Market Insights Pvt. Ltd.
Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.
Phone: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Source: https://www.coherentmarketinsights.com/market-insight/outsourced-drug-discovery-market-2847